Share of Voice used to be a numbers game to increase sales and market share. But with the advent of the digital age, Share of Voice has come to mean more than just numbers.
In this podcast, we discuss a data-driven approach for optimizing congress planning and execution.
A position from MAPS on how Medical Affairs can optimize industry-led and independent Medical Education for maximum value and impact
Drawing on insights from a roundtable of industry leaders convened by Klick at the recent MAPS conference, let’s look at how viewing the KOL holistically can lead to new avenues of engagement and more multifaceted relationships.
In this podcast, we explore now that we appreciate the need to demonstrate impact and technologies exist that allow us to measure impact…what’s holding us back?
Join us for an exciting webinar, co-organized by KSPM and MAPS, that will highlight the critical role of Medical Affairs in the healthcare industry. Industry experts from Korea and global will discuss the strategic value and tangible impact Medical Affairs professionals make in advancing patient care and driving pharmaceutical innovation.
Don’t miss this opportunity to gain insights and join the conversation on the evolving landscape of Medical Affairs!
Addressing the critical importance of integrating robust scientific understanding into the commercial journey, pinpointing the need for medical affairs to take the helm in defining and communicating the commercial value of healthcare innovations.
From the choice of where to publish to the assessment of impact, every decision holds weight in medical research publication. And yet, the metrics that have been traditionally used to guide these decisions offer only a partial view. The result: a hit-or-miss situation when it comes to reaching the target audience—healthcare professionals (HCPs) and patients. Can a data-driven approach that incorporates both traditional and the newer alternative metrics hold the key to improved publication planning, impact and thereby better patient outcomes?
In this podcast, we explore the origins of negative opinions of the pharmaceutical industry, and whether a for-profit model can support both innovation and the society’s best interests.
In this podcast, we ask what is the ONE thing a company must implement in their transformation from the 40-slide deck to modern scientific storytelling.